Squarepoint’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49.1K | Sell |
14,319
-4,431
| -24% | -$15.2K | ﹤0.01% | 2608 |
|
|
2025
Q1 | $41.8K | Sell |
18,750
-38,935
| -67% | -$86.8K | ﹤0.01% | 2632 |
|
|
2024
Q4 | $169K | Buy |
57,685
+44,367
| +333% | +$130K | ﹤0.01% | 2429 |
|
|
2024
Q3 | $34.6K | Sell |
13,318
-55,590
| -81% | -$145K | ﹤0.01% | 2451 |
|
|
2024
Q2 | $204K | Buy |
68,908
+22,132
| +47% | +$65.5K | ﹤0.01% | 2141 |
|
|
2024
Q1 | $212K | Sell |
46,776
-5,231
| -10% | -$23.7K | ﹤0.01% | 2066 |
|
|
2023
Q4 | $297K | Buy |
52,007
+247
| +0.5% | +$1.41K | ﹤0.01% | 1962 |
|
|
2023
Q3 | $238K | Sell |
51,760
-72,628
| -58% | -$334K | ﹤0.01% | 2039 |
|
|
2023
Q2 | $804K | Sell |
124,388
-34,039
| -21% | -$220K | ﹤0.01% | 1383 |
|
|
2023
Q1 | $1.19M | Sell |
158,427
-39,145
| -20% | -$295K | ﹤0.01% | 1076 |
|
|
2022
Q4 | $2M | Buy |
197,572
+148,779
| +305% | +$1.51M | 0.01% | 781 |
|
|
2022
Q3 | $483K | Sell |
48,793
-75,570
| -61% | -$748K | ﹤0.01% | 1416 |
|
|
2022
Q2 | $1.32M | Sell |
124,363
-62,446
| -33% | -$665K | 0.01% | 917 |
|
|
2022
Q1 | $1.82M | Buy |
186,809
+106,528
| +133% | +$1.04M | 0.01% | 846 |
|
|
2021
Q4 | $1.15M | Buy |
80,281
+23,746
| +42% | +$340K | ﹤0.01% | 1151 |
|
|
2021
Q3 | $1.13M | Buy |
56,535
+33,191
| +142% | +$665K | ﹤0.01% | 1027 |
|
|
2021
Q2 | $514K | Buy |
23,344
+7,683
| +49% | +$169K | ﹤0.01% | 1590 |
|
|
2021
Q1 | $532K | Buy |
+15,661
| New | +$532K | ﹤0.01% | 1483 |
|